SCHEMBL6863775

SCHEMBL6863775

CN(C)S(=O)(=O)N(C)CCN(CC(=O)NO)[S+]([O-])c1cc(F)c(Oc2ccc(Cl)cc2)c(F)c1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 9/20 0.37
MMP2 P08253 9/20 0.36
MMP9 P14780 8/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
KMT2A Q03164 1/20 0.35
MMP8 P22894 4/20 0.34
MMP13 P45452 4/20 0.34
MMP14 P50281 3/20 0.34
MMP16 P51512 2/20 0.34
ALDH1A1 P00352 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ADAM17 P78536 3/20 0.33
MMP3 P08254 2/20 0.33
BMP1 P13497 1/20 0.33
MMP7 P09237 1/20 0.32
MEP1B Q16820 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6864813 0.92 MMP1 (0.38) MMP1MMP2MMP9CA2CA9
SCHEMBL6863772 0.85 ALDH1A1 (0.35) MMP1MMP2MMP9CA2CA9
SCHEMBL6864366 0.84 ALDH1A1 (0.34) MMP1MMP2MMP9CA2CA9
SCHEMBL6865493 0.82 MMP3 (0.42) MMP1MMP2MMP9KMT2AMMP13
SCHEMBL6864397 0.81 MMP1 (0.44) MMP1MMP2MMP9CA2CA9
SCHEMBL6864101 0.78 AHCY (0.38) MMP3
SCHEMBL328649 0.73 MMP1 (0.44) MMP1MMP2MMP9CA2CA9
SCHEMBL6864164 0.72 MMP2 (0.33) MMP1MMP2MMP9KMT2AMMP8
SCHEMBL6863163 0.72 MMP1 (0.44) MMP1MMP2MMP9CA2CA9
SCHEMBL328548 0.72 DAGLA (0.37) CA9KMT2AALDH1A1L3MBTL1BMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041545-A1 METHODS OF TREATING ANEURYSMAL DILATATION, BLOOD VESSEL WALL WEAKNESS AND SPECIFICALLY ABDOMINAL AORTIC AND THORACIC ANEURYSM USING MATRIX METALLOPROTEASE-2 INHIBITORS SYMPHONY EVOLUTION, INC. (US) 2011-04-07 WO disclosed